Volume 56, Number 2 (2018)

Volume 56, Number 2 (April - June 2018)

April - June 2018

DOI: 10.65564/pjim.12059c4580


Articles in this Issue

Editorial
The Mexico City Principles and What it Means to Pinoy MD’s

Authors: Francisco P. Tranquilino

DOI: 10.65564/pjim.a426b2d118   |   Published: June 2018

This paper outlines the development, purpose, and regional significance of the Mexico City Principles (MCP) for ethical business practices in the biopharmaceutical sector. The Philippine Food and Drug Administration’s adoption of the MCP further underscores the country’s commitment to ethical industry standards, ensuring that pharmaceutical marketing and promotional activities remain aligned with patient welfare and public trust.
 

Legal Prescription
Solicitation and Fee-splitting are Proscribed (Part 1)

Authors: Rodel V. Capule

DOI: 10.65564/pjim.1087ca13f4   |   Published: June 2018

This legal prescription examines the ethical boundaries between acceptable advertising and prohibited solicitation and fee-splitting within medical practice, as defined by the Philippine Medical Association Code of Ethics and the Medical Act of 1959.

Original Article
Apolipoprotein Levels in Patients with Acute Coronary Syndrome (LIPAS): A Pilot Study

Authors: Elleen L. Cunanan, John Daniel A. Ramos, Mariel I. Barcelon-Cruz, Elmer Jasper B. Llanes, Felix Eduardo R. Punzalan, Paul Ferdinand M. Reganit, Lourdes Ella G. Santos, Rody G. Sy, Jezreel L. Taquiso

DOI: 10.65564/pjim.7aa70332e8   |   Published: June 2018

Lowering levels of low-density lipoprotein cholesterol (LDL-C) are proven to reduce cardiovascular risk. However, some individuals experience acute coronary events despite normal LDL-C levels. Recent studies have focused on modifiable lipoprotein targets, such as apolipoprotein B (apo-B) and apolipoprotein A-1 (apo A-1) and lipoprotein (a), as targets for therapy. Apo-B is the primary apolipoprotein of LDL-C representing total number of atherogenic particles. Apolipoprotein A-1 is the major component of HDL complex. This study will determine the prevalence of elevated apo-B and low apo A-1 among adult Filipinos with acute coronary syndrome (ACS).

Original Article
Insulin Analog Use and Pregnancy Outcomes Among Women with Gestational Diabetes Mellitus (GDM): A Retrospective Analysis at the University of Santo Tomas Hospital

Authors: Kristine S. de Luna, Maria Honolina S. Gomez

DOI: 10.65564/pjim.9056ba9f8e   |   Published: June 2018

Approximately 40% of women with gestational diabetes mellitus (GDM) will require insulin when diet failed to reduce glycemic levels. Insulin analogs have been noted to result in an improved glycemic control and an acceptable safety profile in diabetes mellitus. Our general objective was to evaluate the efficacy, safety, and pregnancy outcomes of insulin analog versus human insulin in women with GDM.

Original Article
The Effect of Whey Protein Supplementation on Duration of Mechanical Ventilation: A Pilot Study

Authors: Kristine Mae Vega-Alava, Rosa Allyn G. Sy

DOI: 10.65564/pjim.859de976b0   |   Published: June 2018

It is important to wean mechanically-ventilated patients as early as possible to avoid complications such as ventilator-associated pneumonia. Supplementing the diet with additional protein may help to stimulate muscle protein synthesis which may enhance respiratory muscle function and ventilator drive. This study aims to determine the effect of whey protein supplementation on the duration of mechanical ventilation in intensive care unit patients of Ospital ng Makati.

Original Article
Hospitalizations, Renal Activity and Damage Incur the Highest Medical Costs Among Filipino Patients with Systemic Lupus Erythematosus

Authors: Elaine T. Veñegas, Kathleen G. Geslani, Sandra V. Navarra

DOI: 10.65564/pjim.2fbd26a117   |   Published: June 2018

Systemic lupus erythematosus (SLE) predominantly affects individuals at peak age of productivity, and medical costs negatively impact on personal, family and community resources. This study aimed to identify annual medical costs and cost predictors among Filipino SLE patients.

Original Article
Assessment of Cognitive Impairment in Systemic Lupus Erythematosus Using the Mini-Mental Status Exam and the Montreal Cognitive Assessment Test-Filipino Version

Authors: Allan D. Corpuz, Angeline Therese D. Magbitang, Ana Teresa S. Hernandez, Kenneth D. Tee, Evelyn Osio-Salido, Bernadette Heizel Manapat-Reyes

DOI: 10.65564/pjim.179eb00a26   |   Published: June 2018

Cognitive impairment (CI) in patients with systemic lupus erythematosus (SLE) presents with or without overt signs of central nervous involvement. The prevalence of CI is variable, ranging from 19-80%. It is often overlooked, leading to high healthcare costs and productivity loss. The usual tools for detection are expensive, time-consuming and not locally available. Detection of CI using the Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment Test (MoCA) is more clinically relevant and practical. The objectives of this study are to determine the prevalence of CI in SLE patients using MMSE/MoCA, to determine the degree of impairment in the different cognitive domains, and to characterize patients with CI in terms of disease activity, education, and employment.

Meta Analysis
Blood Pressure-Lowering Efficacy of Spironolactone in Patients with Resistant Hypertension: A Meta-analysis

Authors: Mithi Kalayaan Zamora, Jeremiah Vallente, Raymond Oliva

DOI: 10.65564/pjim.14126d6872   |   Published: June 2018

Resistant hypertension (RH) is defined as a blood pressure (BP) reading that remains above goal despite concurrent use of three optimally dosed anti-hypertensives of different classes, including a diuretic. Spironolactone, a mineralocorticoid receptor antagonist, has shown significant benefit in reduction of BP in recent trials and is used empirically as an add-on therapy for RH. The researchers’ objective is to evaluate the BP-lowering efficacy of spironolactone in patients with resistant hypertension.

Case Report
Superior Mesenteric Artery Syndrome: A Rare and Unusual Cause of Gastrointestinal Obstruction

Authors: Emily Mae Yap, Ana Beatriz Medrano, Ira Inductivo-Yu

DOI: 10.65564/pjim.1416f9718d   |   Published: June 2018

Superior mesenteric artery (SMA) syndrome is a rare and unusual acquired cause of functional duodenal obstruction whose diagnosis can be easily missed without knowledge of this condition. We report a case of a 27-year-old female, presenting with post-prandial vomiting, early satiety, bloatedness and weight loss for about 10 months.

Case Report
Congenitally Absent Right Coronary Artery with a Coronary Artery Fistula From the Left Anterior Descending Artery to the Main Pulmonary Artery: A Case Report

Authors: Lucky R. Cuenza, Eduardo Tin Hay

DOI: 10.65564/pjim.11e7374c2a   |   Published: June 2018

Single coronary artery and coronary artery fistulas are unusual findings either alone or in combination. They may be incidental findings or can present with myocardial ischemia. A 46-year-old male had chest pain accompanied by heart failure symptoms. He sought consult in our institution where further workups revealed that he suffered an acute coronary syndrome.

Case Report
Steroid-Responsive Miller-Fisher Variant of Guillain-Barré Syndrome in a 25-year Old Male: A Case Report

Authors: Shayne Julieane Morales

DOI: 10.65564/pjim.2ecfe822fc   |   Published: June 2018

Miller Fisher syndrome (MFS) is a variant of Guillain-Barré syndrome (GBS) characterized by an immune-mediated polyneuropathy. Diagnosis is largely clinical and spontaneous recovery is observed in most cases. Treatment options such as IVIg, plasmapheresis, and steroids have been studied as options to shorten the disease course, but with inconclusive results. A 25-year-old male complained of sudden onset diplopia, gait instability and hand parasthesia.

Clinical Trials
A Post-Marketing Surveillance Study to Evaluate the Efficacy and Safety of Sevelamer Carbonate in the Management of Chronic Kidney Disease- Related Hyperphosphatemia in the Philippines

Authors: Romina Danguilan

DOI: 10.65564/pjim.16e8038f69   |   Published: June 2018

This is a prospective, post marketing surveillance study that aims to determine the efficacy and safety of sevelamer carbonate in hyperphosphatemic chronic kidney disease (CKD) patients in the Philippines.